To access this element change to forms mode OFF
Grant Award View - GA188765-V1
Industrial biotechnology for the manufacture of alkaloid pharmaceuticals
GA ID:
GA188765-V1
Agency:
Australian Research Council
Approval Date:
13-Sep-2021
Variation Publish Date:
6-Oct-2021
Variation Date:
13-Sep-2021
Category:
Science, Technology, Engineering and Mathematics (STEM) Research
Grant Term:
13-Sep-2021 to 30-Jun-2024
Value (AUD):
$522,000.00
(GST inclusive where applicable)
Varies:
GA188765
- Industrial biotechnology for the manufacture of alkaloid pharmaceuticals
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
ARC 21/22 Linkage
Grant Program:
Linkage Projects
Grant Activity:
Industrial biotechnology for the manufacture of alkaloid pharmaceuticals
Purpose:
Drugs that treat opioid dependence and overdose are increasingly needed but their manufacture is difficult, inefficient and expensive. This project aims to develop enzymatic N-demethylation as a simpler and more sustainable approach to the manufacture and modification of opioid antagonists, alkaloids and other drug targets. It will increase our understanding of enzymatic N-demethylation and address engineering and biotechnology challenges to improve yield and product isolation and concentration. Improvements in drug manufacturing processes will assist drug affected communities and industry will benefit from value adding, greater market share and flexibility, increased innovation and de-risked processes and new products.
GO ID:
GO Title:
Linkage Projects for funding applied for in 2020
Internal Reference ID:
LP20 Round 3
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
The University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
UNIVERSITY OF MELBOURNE
Town/City:
UNIVERSITY OF MELBOURNE
Postcode:
3010
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3010
Country:
AUSTRALIA